ResMed Inc. RMD
$218.27
-$1.31-0.60%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 2.25% | 0.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.25% | 0.60% | |||
| Cost of Revenue | 11.56% | -0.69% | |||
| Gross Profit | -3.26% | 1.39% | |||
| SG&A Expenses | 4.85% | 1.49% | |||
| Depreciation & Amortization | -1.57% | -2.43% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.32% | 0.35% | |||
| Operating Income | -10.68% | 1.07% | |||
| Income Before Tax | -5.60% | 1.24% | |||
| Income Tax Expenses | -12.40% | 0.02% | |||
| Earnings from Continuing Operations | -3.84% | 1.56% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -3.84% | 1.56% | |||
| EBIT | -10.68% | 1.07% | |||
| EBITDA | -12.20% | 2.65% | |||
| EPS Basic | -3.42% | 1.91% | |||
| Normalized Basic EPS | -7.74% | 3.09% | |||
| EPS Diluted | -3.55% | 2.24% | |||
| Normalized Diluted EPS | -7.67% | 3.20% | |||
| Average Basic Shares Outstanding | -0.44% | -0.34% | |||
| Average Diluted Shares Outstanding | -0.51% | -0.44% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.04% | -0.02% | |||